Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Steve Lichtman is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/30/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/17/2024 | PEN | Buy Now | Penumbra | $266.03 | 3.37% | Steve Lichtman60% | → $275 | Initiates | → Outperform | Get Alert |
| 12/17/2024 | NARI | Buy Now | Inari Medical | — | — | Steve Lichtman60% | → $75 | Initiates | → Outperform | Get Alert |
